Free Trial
NASDAQ:KRMD

KORU Medical Systems Q2 2025 Earnings Report

KORU Medical Systems logo
$3.28 -0.10 (-2.96%)
Closing price 08/5/2025 04:00 PM Eastern
Extended Trading
$3.28 0.00 (0.00%)
As of 08/5/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Upcoming Event
Earnings Conference Call
KORU Medical Systems Q2 2025
00:00 / 00:00
Live Transcript
Follow Audio

KORU Medical Systems EPS Results

Actual EPS
N/A
Consensus EPS
-$0.03
Beat/Miss
N/A
One Year Ago EPS
N/A

KORU Medical Systems Revenue Results

Actual Revenue
N/A
Expected Revenue
$9.46 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

KORU Medical Systems Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Wednesday, August 6, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

KORU Medical Systems Earnings Headlines

Elon Leaves DOGE? Here’s What’s Next…
Early investors in Tesla saw 30,000% returns. SpaceX? Similar story. Now, Elon Musk is going all-in on something even bigger: artificial superintelligence. He’s calling it the next evolution of AI—and insiders are already calling it “AI 2.0.” The project is advancing quickly, and a key update could be announced as early as this summer. You can’t invest directly in Elon’s new tech—but there’s a backdoor way in.
See More KORU Medical Systems Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like KORU Medical Systems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on KORU Medical Systems and other key companies, straight to your email.

About KORU Medical Systems

KORU Medical Systems (NASDAQ:KRMD) develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

View KORU Medical Systems Profile

More Earnings Resources from MarketBeat